"Rank","Title","Status","Study Results","Conditions","Interventions","Locations","URL"
1,"Inactivated Influenza A/H9N2 Vaccine With and Without MF59 Adjuvant in Ambulatory Adults","Completed","No Results Available","Influenza","Biological: Influenza A/H9N2 vaccine|Drug: MF59 adjuvant","Baylor College of Medicine, Houston, Texas, United States","https://ClinicalTrials.gov/show/NCT00133471"
2,"A Phase 1/2 Clinical Trial of an Alphavirus Replicon Vaccine for Influenza","Completed","No Results Available","Influenza","Biological: AVX502|Biological: Placebo","Johnson County Clin-Trials, Lenexa, Kansas, United States","https://ClinicalTrials.gov/show/NCT00440362"
3,"Safety and Immunogenicity of Inactivated Influenza Virus Vaccine Among Healthy Children 6-12 Weeks of Age","Completed","No Results Available","Inactivated Influenza Vaccine","Biological: 2005-2006 trivalent inactivated influenza vaccine","Seattle Children's Hospital and Regional Medical Center, Seattle, Washington, United States","https://ClinicalTrials.gov/show/NCT00242424"
4,"Influenza Immunity Against Pandemic Respiratory Virus","Completed","No Results Available","Influenza","Biological: FluMist|Biological: Fluzone","Stanford University, Stanford, California, United States","https://ClinicalTrials.gov/show/NCT00138281"
5,"St. Jude Open Label H5 Trial","Completed","No Results Available","Influenza","Biological: Inactivated Influenza A/H5N1 Vaccine (sanofi pasteur)","St. Jude Children's Research Hospital, Memphis, Tennessee, United States","https://ClinicalTrials.gov/show/NCT00311675"
6,"Proteomic Profiling for Influenza Vaccination - FluMist","Completed","No Results Available","Influenza","Biological: FluMist","Eastern Virginia Medical School, Norfolk, Virginia, United States","https://ClinicalTrials.gov/show/NCT00385281"
7,"Interferon as a Mucosal Adjuvant for Influenza Vaccine Given Intranasally","Completed","Has Results","Influenza","Biological: Trivalent inactivated influenza virus vaccine (2006-2007 formulation)|Biological: Type 1 interferon","Baylor College of Medicine, Houston, Texas, United States","https://ClinicalTrials.gov/show/NCT00436046"
8,"Immunogenicity and Safety of Different Doses of Fluzone® Influenza","Completed","No Results Available","Influenza","Biological: Fluzone® (IM)|Biological: Fluzone®","Saint Louis University, St. Louis, Missouri, United States","https://ClinicalTrials.gov/show/NCT00253734"
9,"Revaccination With Subunit Influenza A/Vietnam/1203/2004 (H5N1) Vaccine","Completed","No Results Available","Influenza","Biological: Influenza A/Vietnam/1203/2004 (H5N1; sanofi pasteur)","University of Rochester, Rochester, New York, United States","https://ClinicalTrials.gov/show/NCT00240903"
10,"A Study to Evaluate the Safety and Immune Responses to Fluzone® Vaccination","Completed","Has Results","Influenza","Biological: Influenza virus vaccine","Norfolk, Virginia, United States","https://ClinicalTrials.gov/show/NCT00835926"
11,"Safety and Immunogenicity of the 2005-2006 Fluzone® Vaccine","Completed","Has Results","Influenza","Biological: Fluzone®: Influenza Virus Vaccine","Norfolk, Virginia, United States","https://ClinicalTrials.gov/show/NCT00258830"
12,"Safety and Immunogenicity of the World Health Organization (WHO) Formulation of the 2004-2005 Fluzone® Vaccine","Completed","Has Results","Influenza","Biological: Fluzone®: Influenza virus vaccine 2004-2005 formulation","Norfolk, Virginia, United States","https://ClinicalTrials.gov/show/NCT00831987"
13,"Study to Collect Sera for Immunogenicity Testing in Children Vaccinated With Fluzone®","Completed","Has Results","Influenza","Biological: Influenza virus vaccine (Pediatric formulation)","Norfolk, Virginia, United States","https://ClinicalTrials.gov/show/NCT00836953"
14,"Phase IV Trial to Collect Safety Data and Sera in Healthy Children Given Fluzone Vaccine","Completed","Has Results","Influenza","Biological: Influenza Virus Vaccine (Fluzone®)","Norfolk, Virginia, United States","https://ClinicalTrials.gov/show/NCT00258817"
15,"Trial to Describe the Safety and Immunogenicity of Fluzone®","Completed","Has Results","Influenza","Biological: Inactivated, Split-Virion Influenza Virus","Norfolk, Virginia, United States","https://ClinicalTrials.gov/show/NCT00524940"
16,"Study of Safety and Immunogenicity of Fluzone® in Healthy Children","Completed","Has Results","Influenza","Biological: Influenza Vaccine 2004-2005 Paediatric Formulation","Norfolk, Virginia, United States","https://ClinicalTrials.gov/show/NCT00831675"
17,"Trivalent Baculovirus-expressed Influenza HA Vaccine in Adults With Non-Hodgkin's B-cell Lymphoma","Completed","No Results Available","Influenza","Biological: Trivalent inactivated influenza vaccine|Biological: Trivalent Baculovirus-expressed Influenza HA vaccine","University of Texas MD Anderson Cancer Center, Houston, Texas, United States","https://ClinicalTrials.gov/show/NCT00307177"
18,"Half vs Full Dose Influenza Vaccine","Completed","No Results Available","Influenza","Biological: Fluzone® (Aventis Pasteur inactivated influenza vaccine)","Pentagon, Washington, District of Columbia, United States|Walter Reed Army Medical Center, Washington, District of Columbia, United States","https://ClinicalTrials.gov/show/NCT00283283"
19,"Phase II Study to Investigate the Kinetics of the Immune Response Generated by Influenza Virus Vaccine.","Completed","No Results Available","Influenza","Biological: CAIV-T|Biological: TIV|Biological: Placebo","David M. Radin, MD, Stamford, Connecticut, United States","https://ClinicalTrials.gov/show/NCT00192309"
20,"Inactivated Influenza Vaccine in Infants 10-22 Weeks of Age","Completed","No Results Available","Influenza","Biological: Fluzone","Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, United States|Vanderbilt University, Nashville, Tennessee, United States","https://ClinicalTrials.gov/show/NCT00231920"
21,"H5N1 Vaccine Intramuscular Versus Intradermal in Healthy Adults","Completed","No Results Available","Influenza","Biological: Inactivated Influenza A Vaccine A/H5N1","Baylor College of Medicine, Houston, Texas, United States","https://ClinicalTrials.gov/show/NCT00310206"
22,"Trial to Collect Safety Data and Sera for Immunogenicity Testing","Completed","Has Results","Influenza","Biological: Influenza Virus Vaccine (Fluzone®)","Norfolk, Virginia, United States","https://ClinicalTrials.gov/show/NCT00389857"
23,"Trial to Investigate Immune Responses Elicited by a Liquid Formulation of Influenza Virus Vaccine (CAIV-T) in Healthy Children","Completed","No Results Available","Influenza","Biological: CAIV-T 10^7|Biological: CAIVT 10^5|Biological: Placebo|Biological: TIV","Suncoast Clinical Research, Inc., New Port Richey, Florida, United States|Division of Allergy Immunology and Infectious Disease, Pittsburgh, Pennsylvania, United States","https://ClinicalTrials.gov/show/NCT00192322"
24,"Open Label Evaluation of H5N1 Vaccine at Vaccine Manufacturing Facilities","Completed","No Results Available","Influenza","Biological: Inactivated Influenza A Vaccine A/H5N1","Sanofi Pasteur, Swiftwater, Pennsylvania, United States","https://ClinicalTrials.gov/show/NCT00311649"
25,"Safety and Dose Study of Peramivir for Influenza Treatment","Completed","No Results Available","Influenza","Drug: Peramivir","National Institutes of Health Clinical Center, 9000 Rockville Pike, Bethesda, Maryland, United States","https://ClinicalTrials.gov/show/NCT00297050"
26,"Single Group Study of the Safety of and Immune Response to a Bird Flu Vaccine (H7N3) in Healthy Adults","Completed","No Results Available","Influenza|Virus Diseases","Biological: Live Influenza A Vaccine H7N3 (6-2) AA ca Recombinant (A/chicken/British Columbia/CN-6/2004 x A/Ann Arbor/6/60 ca)","Center for Immunization Research Inpatient Unit, Mason F. Lord Building, 4940 Eastern Avenue, Baltimore, Maryland, United States","https://ClinicalTrials.gov/show/NCT00516035"
27,"Safety of and Immune Response to a Bird Flu Virus Vaccine (H9N2) in Healthy Adults (Study B)","Completed","No Results Available","Influenza|Virus Diseases","Biological: H9N2 (6-2) AA ca Reassortant (A/Chicken/Hong Kong/G9/97 x A/Ann Arbor/6/60 ca)","Center for Immunization Research Inpatient Unit, Mason F. Lord Building, Johns Hopkins Bayview Medical Center, Baltimore, Maryland, United States","https://ClinicalTrials.gov/show/NCT00380237"
28,"Safety of and Immune Response to a Bird Flu Virus Vaccine (H5N1) in Healthy Adults","Completed","No Results Available","Influenza|Virus Diseases","Biological: H5N1 (6-2) AA ca Recombinant (A/VietNam/1203/2004 x A/AnnArbor/6/60/ca)","Center of Immunization Research (CIR), Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, United States","https://ClinicalTrials.gov/show/NCT00347672"
29,"Safety of and Immune Response to a Bird Flu Virus Vaccine (H9N2) in Healthy Adults (Study A)","Completed","No Results Available","Influenza|Virus Diseases","Biological: H9N2 (6-2) AA ca Reassortant (A/chicken/Hong Kong/G9/97 x A/Ann Arbor/6/60 ca)","Johns Hopkins School of Public Health, Baltimore, Maryland, United States","https://ClinicalTrials.gov/show/NCT00110279"
30,"Study to Evaluate the Effectiveness of FluMist Vaccination in a School-Based Intervention Program","Completed","No Results Available","Influenza","Biological: FluMist","Division of General Pediatrics, University of Maryland School of Medicine, Baltimore, Maryland, United States|Division of Allergy and Infectious Diseases, University of Washington School of Medicine, Seattle, Washington, United States","https://ClinicalTrials.gov/show/NCT00192218"
31,"Evaluation of Alternative Oseltamivir (Tamiflu) Dosing Strategies.","Completed","No Results Available","Influenza","Drug: Oseltamivir|Drug: Probenecid","VA Palo Alto Health Care System, Palo Alto, California, United States","https://ClinicalTrials.gov/show/NCT00304434"
32,"Immunogenicity and Safety of Trivalent Recombinant Hemagglutinin Influenza Vaccine in Healthy Adults","Completed","No Results Available","Influenza","Biological: Influenza Vaccine, recombinant Hemagglutinin","Rochester Medical Center, Rochester, New York, United States|Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, United States|University of Virginia Health System, Charlottesville, Virginia, United States","https://ClinicalTrials.gov/show/NCT00328107"
33,"Immunogenicity and Safety of FluBlok Trivalent Recombinant Hemagglutinin Influenza Vaccine in Healthy Pediatrics","Completed","No Results Available","Influenza","Biological: Influenza Vaccination","Kentucky pediatric /Adult Research, Bardstown, Kentucky, United States|Saint Louis University, Saint Louis, Missouri, United States|Primary Physicians Research, Pittsburg, Pennsylvania, United States","https://ClinicalTrials.gov/show/NCT00336453"
34,"Open-Label Study of H5 Vaccine in Participants of Protocol 04-077","Completed","Has Results","Influenza","Biological: Inactivated Influenza A/H5N1 Vaccine (sanofi pasteur)","UCLA Center For Vaccine Research, Torrance, California, United States|University of Maryland Baltimore, Baltimore, Maryland, United States|Saint Louis University, St. Louis, Missouri, United States","https://ClinicalTrials.gov/show/NCT00402649"
35,"A Phase I Safety and Immunogenicity Study of Mix and Match of Licensed Flu Vaccine and Flumist","Completed","No Results Available","Influenza","Biological: FluMist|Biological: Fluzone","Saint Louis University, St. Louis, Missouri, United States|Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, United States|Vanderbilt University, Nashville, Tennessee, United States","https://ClinicalTrials.gov/show/NCT00231907"
36,"Influenza Vaccination in Patients Receiving Antineoplastic Therapy for Non-Hodgkin's Lymphoma","Completed","No Results Available","Lymphoma","Biological: Trivalent Baculovirus-expressed Influenza HA vaccine","U.T.M.D. Anderson Cancer Center, Houston, Texas, United States","https://ClinicalTrials.gov/show/NCT00307710"
37,"Inactivated Influenza A/H5N1 Vaccine in the Elderly","Completed","No Results Available","Influenza","Biological: Influenza A/H5N1 Vaccine|Drug: Placebo","UCLA Center For Vaccine Research, Torrance, California, United States|University of Rochester Medical Center - Strong Memorial Hospital - Infectious Diseases, Rochester, New York, United States|Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, United States|Vanderbilt University, Nashville, Tennessee, United States","https://ClinicalTrials.gov/show/NCT00230750"
38,"H5 Booster After a Two Dose Schedule","Completed","No Results Available","Influenza","Biological: Inactivated Influenza A/H5N1 Vaccine (sanofi pasteur)","UCLA Center For Vaccine Research, Torrance, California, United States|University of Maryland Baltimore, Baltimore, Maryland, United States|University of Rochester Medical Center - Strong Memorial Hospital - Infectious Diseases, Rochester, New York, United States","https://ClinicalTrials.gov/show/NCT00240968"
39,"H5 Adult - Chiron Study of Bird Flu Vaccine","Completed","No Results Available","Influenza","Biological: Aluminum hydroxide|Biological: Inactivated Influenza A/H5N1 Vaccine (Chiron)|Biological: MF-59|Drug: Placebo","Stanford University, Stanford, California, United States|Saint Louis University, St. Louis, Missouri, United States|Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, United States|Vanderbilt University, Nashville, Tennessee, United States","https://ClinicalTrials.gov/show/NCT00280033"
40,"Study to Evaluate the Safety of a Monovalent Vaccine of a New 6:2 Reassortant in Healthy Adults (AV024)","Completed","No Results Available","Influenza","Biological: AV024|Other: Placebo","SFBC International Inc, Miami, Florida, United States","https://ClinicalTrials.gov/show/NCT00240877"
41,"H5 Vaccine Alone or With Adjuvant in Healthy Adults","Completed","No Results Available","Influenza","Drug: Aluminum hydroxide|Biological: Inactivated Influenza A/H5N1 Vaccine (sanofi pasteur pre-adsorbed)","University of Maryland Baltimore, Baltimore, Maryland, United States|University of Rochester, Rochester, New York, United States|Duke University Medical Center, Durham, North Carolina, United States|Baylor College of Medicine, Houston, Texas, United States","https://ClinicalTrials.gov/show/NCT00296634"
42,"A/H5N1 Vaccine in Healthy Children Aged 2-9 Years","Completed","No Results Available","Influenza","Biological: Influenza A/H5N1 Vaccine|Drug: Placebo","UCLA Center For Vaccine Research, Torrance, California, United States|University of Maryland Baltimore, Baltimore, Maryland, United States|Saint Louis University, St. Louis, Missouri, United States|Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, United States","https://ClinicalTrials.gov/show/NCT00133536"
43,"Study of the Safety and Immunogenicity of an Influenza Vaccine Administered to Healthy Adults","Completed","Has Results","Influenza Disease; Flu","Biological: Influenza Virus Vaccine","Bardstown, Kentucky, United States|Pittsburgh, Pennsylvania, United States|Salt Lake City, Utah, United States|Salt Lake City, Utah, United States","https://ClinicalTrials.gov/show/NCT00264576"
44,"Alternative Oseltamivir Dosing Strategies","Completed","No Results Available","Influenza","Drug: Oseltamivir","VA Greater Los Angeles Healthcare System, Los Angeles, California, United States|VA Palo Alto Health Care System, Palo Alto, California, United States|National Institutes of Health Clinical Center, 9000 Rockville Pike, Bethesda, Maryland, United States|Brooke Army Medical Center, Houston, Texas, United States","https://ClinicalTrials.gov/show/NCT00334529"
45,"Safety and Immunogenicity of Fluzone® Vaccine in Children Who Received 2 Doses of the 2005-2006 Fluzone Formulation.","Completed","Has Results","Influenza","Biological: Influenza Virus Vaccine, Fluzone®","Layton, Utah, United States|Pleasant Grove, Utah, United States|Provo, Utah, United States|Salt Lake City, Utah, United States|South Jordan, Utah, United States","https://ClinicalTrials.gov/show/NCT00390884"
46,"Study to Evaluate the Immune Responses of Trivalent Cold-Adapted Influenza Vaccine (CAIV-T) Compared With (TIV)","Completed","No Results Available","Influenza","Biological: CAIV-T|Other: TIV","Wee Care Pediatrics, Layton, Utah, United States|Bear Care Pediatrics, Ogden, Utah, United States|Alpine Pediatrics, Pleasant Grove, Utah, United States|Utah Valley Pediatrics, Provo, Utah, United States|Families First Pediatrics, South Jordan, Utah, United States","https://ClinicalTrials.gov/show/NCT00111579"
47,"Dose-Escalating Trial Using Vero Cell-culture Derived H5N1 +/- Aluminum in Adults","Completed","No Results Available","Influenza","Biological: Aluminum hydroxide|Biological: Inactivated Vero cell based whole virus influenza A/H5N1|Drug: Placebo","Stanford University, Stanford, California, United States|UCLA Center For Vaccine Research, Torrance, California, United States|University of Maryland School of Medicine, Baltimore, Maryland, United States|Vanderbilt University, Nashville, Tennessee, United States|Baylor College of Medicine, Houston, Texas, United States","https://ClinicalTrials.gov/show/NCT00382980"
48,"Studies of Influenza Vaccine and Tetanus-Pneumococcal Vaccine in HIV-infected Patients Receiving Interleukin-2","Completed","No Results Available","HIV Infections","Drug: Interleukin-2","National Institutes of Health Clinical Center, 9000 Rockville Pike, Bethesda, Maryland, United States|Hvidovre University Hospital@@@Copenhagen, Denmark, Copenhagen, Denmark","https://ClinicalTrials.gov/show/NCT00050726"
49,"FLU-VACS Comparative Study in Adults","Completed","No Results Available","Influenza","Biological: Cold-adapted live attenuated influenza virus vaccine, trivalent|Other: Placebo|Biological: Trivalent inactivated influenza vaccine","Ann Arbor West, Ann Arbor, Michigan, United States|University of Michigan, Ann Arbor, Michigan, United States|Western Michigan University Health Services, Kalamazoo, Michigan, United States|Livonia East, Livonia, Michigan, United States|Central Michigan University Health Services, Mt. Pleasant, Michigan, United States|Eastern Michigan University Health Services, Ypsilanti, Michigan, United States","https://ClinicalTrials.gov/show/NCT00133523"
50,"Evaluation of Responses to Fluzone® in Infants ≥ 6 Months of Age Who Did or Did Not Receive Fluzone® at 2 Months of Age","Completed","Has Results","Influenza","Biological: Influenza Virus Vaccine","Little Rock, Arkansas, United States|Marietta, Georgia, United States|Durham, North Carolina, United States|Dayton, Ohio, United States|Pittsburgh, Pennsylvania, United States|Seattle, Washington, United States","https://ClinicalTrials.gov/show/NCT00885105"
51,"Safety and Immunogenicity Testing of Influenza Vaccine in Healthy Children 2 Months and 6 Months of Age","Completed","Has Results","Influenza","Biological: Influenza virus vaccine (2004-2005 Formulation)","Little Rock, Arkansas, United States|Marietta, Georgia, United States|Durham, North Carolina, United States|Akron, Ohio, United States|Dayton, Ohio, United States|Pittsburgh, Pennsylvania, United States|Norfolk, Virginia, United States|Seattle, Washington, United States","https://ClinicalTrials.gov/show/NCT00858468"
52,"Evaluation of the Efficacy and Safety of Peramivir in Subjects With Uncomplicated Acute Influenza.","Completed","Has Results","Influenza","Drug: Peramivir 150 mg|Drug: Peramivir 300 mg|Drug: Placebo","Radiant Research, Birmingham, Alabama, United States|Clopton Clinic, Jonesboro, Arkansas, United States|Advanced Clinical Research Institute, Anaheim, California, United States|Orange County Clinical Trials, Anaheim, California, United States|Medical Center, Carmichael, California, United States|Pacific Sleep Medicines Service, El Centro, California, United States|Advanced Clinical Research Institute, Orange, California, United States|Benchmark Research, Sacramento, California, United States|Pacific Sleep Medicine Services, San Diego, California, United States|Pacific Sleep Medicine Services, San Francisco, California, United States|Alpine Clinical Research Center, Boulder, Colorado, United States|George Washington Unviersity, Washington, District of Columbia, United States|Clinical Research of Southern Florida, Coral Gables, Florida, United States|University Clinical Research-Deland, LLC, DeLand, Florida, United States|Florida Medical Research Institute, Gainesville, Florida, United States|Jacksonville Center for Clinical Research, Jacksonville, Florida, United States|Jacksonville Center for Clinical Research, Jacksonville, Florida, United States|Clinical Research Center, Sarasota, Florida, United States|Palm Beach Research Center, West Palm Beach, Florida, United States|Georgia Clinical Research, Atlanta, Georgia, United States|Wishard Hospital, Indianapolis, Indiana, United States|Radiant Research, Overland Park, Kansas, United States|Kentucky Pediatric / Adult Research, Bardstown, Kentucky, United States|Central Kentucky Research Assoc, Inc, Lexington, Kentucky, United States|Benchmark Research, Metairie, Louisiana, United States|Radiant Research, Minneapolis, Edina, Minnesota, United States|Barnes-Jewish Hospital Emergency Department, St Louis, Missouri, United States|Medex Healthcare Research, Inc., St. Louis, Missouri, United States|Radiant Research, St. Louis, Missouri, United States|Bozeman Urgent Care Center, Bozeman, Montana, United States|Alliance Medical Center, Alliance, Nebraska, United States|Midwest Family Physicians, Omaha, Nebraska, United States|UMDNJ, Cherry Hill, New Jersey, United States|Pulmonary & Critical Care Associates, East Brunswick, New Jersey, United States|Brooklyn Hospital Center, Brooklyn, New York, United States|Wake Research Associates, LLC, Raleigh, North Carolina, United States|Summa Health, Akron, Ohio, United States|Sterling Research Group, LTD., Cincinnati, Ohio, United States|Integrated Medical Research, PC, Ashland, Oregon, United States|Research Across America at Oyster Point Family Health Center, Lancaster, Pennsylvania, United States|Radiant Research, Philadelphia, Pennsylvania, United States|Primary Physicians Research, Inc, Pittsburgh, Pennsylvania, United States|New England Center for Clinical Research, Inc, Cranston, Rhode Island, United States|Paragon Clinical Research, Inc., Cranston, Rhode Island, United States|Omega Medical Research, Warwick, Rhode Island, United States|Hillcrest Family Practice, Simpsonville, South Carolina, United States|Research Across America, Dallas, Texas, United States|Radiant Research, Dallas, Texas, United States|Towngate Plaza Medical Center, Garland, Texas, United States|Baylor Clinic-Baylor College of Medicine, Houston, Texas, United States|GSA Research, San Antonio, Texas, United States|Radiant Research-San Antonio Northeast, San Antonio, Texas, United States|Radiant Research San Antonio, San Antonio, Texas, United States|Balbir Chahal M.D. ,P.A, Tomball, Texas, United States|Dynamed Clinical Research, Tomball, Texas, United States|J. Lewis Research, Inc. Foothill Family Clinic, Salt Lake City, Utah, United States|J. Lewis Research, Inc. Foothill Family Clinic South, Salt Lake City, Utah, United States|J. Lewis Research, Inc./Southwest Family Medicine, West Jordan, Utah, United States|Calgary West Medical Cnetre Clinical Studies, Calgary, Alberta, Canada|Belvedere Medicentre, Edmonton, Alberta, Canada|Hermitage Medicentres, Edmonton, Alberta, Canada|RJA Medicentres, Edmonton, Alberta, Canada|Castledowns Medicentre, Edmonton, Alberta, Canada|Gain Medical Centre, Coquitlam, British Columbia, Canada|Source Unique Clinic, Hawkesbury, Ontario, Canada|Manna Research, Toronto, Ontario, Canada|Omnispec Clinical Reasearch Inc, Mirabel, Quebec, Canada|Clinique Medicale des Campus, Ste-Foy, Quebec, Canada|Prairie Clinical, Saskatoon, Saskatchewan, Canada","https://ClinicalTrials.gov/show/NCT00419263"
53,"Study on the Incidence of Influenza and Its Complications, in Subjects Aged 50 Years and Over Vaccinated With Fluarix™","Completed","Has Results","Influenza","Biological: Fluarix™","GSK Investigational Site, Mobile, Alabama, United States|GSK Investigational Site, Delray Beach, Florida, United States|GSK Investigational Site, Pembroke Pines, Florida, United States|GSK Investigational Site, Las Vegas, Nevada, United States|GSK Investigational Site, Somers Point, New Jersey, United States|GSK Investigational Site, Camillus, New York, United States|GSK Investigational Site, Raleigh, North Carolina, United States|GSK Investigational Site, Pittsburgh, Pennsylvania, United States|GSK Investigational Site, Norfolk, Virginia, United States|GSK Investigational Site, Gueglingen, Baden-Wuerttemberg, Germany|GSK Investigational Site, Rudersberg, Baden-Wuerttemberg, Germany|GSK Investigational Site, Weinheim, Baden-Wuerttemberg, Germany|GSK Investigational Site, Potsdam, Brandenburg, Germany|GSK Investigational Site, Frankfurt/Main, Hessen, Germany|GSK Investigational Site, Essen, Nordrhein-Westfalen, Germany|GSK Investigational Site, Witten, Nordrhein-Westfalen, Germany|GSK Investigational Site, Mainz, Rheinland-Pfalz, Germany|GSK Investigational Site, Rhaunen, Rheinland-Pfalz, Germany|GSK Investigational Site, Magdeburg, Sachsen-Anhalt, Germany|GSK Investigational Site, Dresden, Sachsen, Germany|GSK Investigational Site, Leipzg, Sachsen, Germany|GSK Investigational Site, Leipzig, Sachsen, Germany|GSK Investigational Site, Leipzig, Sachsen, Germany|GSK Investigational Site, Berlin, Germany|GSK Investigational Site, Berlin, Germany|GSK Investigational Site, Berlin, Germany|GSK Investigational Site, Hamburg, Germany|GSK Investigational Site, Hamburg, Germany|GSK Investigational Site, Hamburg, Germany|GSK Investigational Site, Hamburg, Germany|GSK Investigational Site, Utrecht, Netherlands|GSK Investigational Site, Debica, Poland|GSK Investigational Site, Krakow, Poland|GSK Investigational Site, Mielec, Poland|GSK Investigational Site, Porabka, Poland|GSK Investigational Site, Siemianowice Slaskie, Poland|GSK Investigational Site, Wroclaw, Poland","https://ClinicalTrials.gov/show/NCT00377611"
54,"H5 Vaccine Alone or With Aluminum Hydroxide in Elderly Adults","Completed","No Results Available","Influenza","Biological: Aluminum hydroxide|Biological: Inactivated Influenza A/H5N1 Vaccine (sanofi pasteur)","University of Iowa, Iowa City, Iowa, United States|University of Maryland Baltimore, Baltimore, Maryland, United States|Saint Louis University, St. Louis, Missouri, United States|University of Rochester, Rochester, New York, United States|Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, United States|Vanderbilt University - Pediatric - Vanderbilt Vaccine Research Center, Nashville, Tennessee, United States|Baylor College of Medicine, Houston, Texas, United States","https://ClinicalTrials.gov/show/NCT00294099"
55,"Immunogenicity, Safety and Tolerability of CSL Limited Inactivated Influenza Vaccine in Adults","Completed","No Results Available","Influenza","Biological: CSL Trivalent Inactivated Influenza Vaccine - Thimerosal-free|Biological: CSL Trivalent Inactivated Influenza Vaccine with Thimerosal|Biological: Placebo with Thimerosal","Stanford University, Stanford, California, United States|University of Iowa, Iowa City, Iowa, United States|University of Maryland Baltimore, Baltimore, Maryland, United States|Saint Louis University, St. Louis, Missouri, United States|University of Rochester, Rochester, New York, United States|Duke University Medical Center, Durham, North Carolina, United States|Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, United States|Vanderbilt University, Nashville, Tennessee, United States|Baylor College of Medicine, Houston, Texas, United States|Clinical Alliance for Research & Education - Infectious Diseases, Annandale, Virginia, United States","https://ClinicalTrials.gov/show/NCT00333398"
56,"Evaluate Safety & Immunogenicity of GSK Bio's Influenza Vaccine GSK576389A After Repeated Vaccination in Elderly Adults","Completed","Has Results","Influenza","Biological: Fluarix|Biological: GSK Biologicals Influenza Vaccine GSK576389A","GSK Investigational Site, Clearwater, Florida, United States|GSK Investigational Site, Coral Gables, Florida, United States|GSK Investigational Site, Milford, Massachusetts, United States|GSK Investigational Site, Chaska, Minnesota, United States|GSK Investigational Site, Somers Point, New Jersey, United States|GSK Investigational Site, Poughkeepsie, New York, United States|GSK Investigational Site, Carnegie, Pennsylvania, United States|GSK Investigational Site, Erie, Pennsylvania, United States|GSK Investigational Site, Pittsburgh, Pennsylvania, United States|GSK Investigational Site, Gent, Belgium|GSK Investigational Site, Messkirch, Baden-Wuerttemberg, Germany|GSK Investigational Site, Augsburg, Bayern, Germany|GSK Investigational Site, Haag, Bayern, Germany|GSK Investigational Site, Hoehenkirchen-Siegertsbrunn, Bayern, Germany|GSK Investigational Site, Langquaid, Bayern, Germany|GSK Investigational Site, Ruedersdorf, Brandenburg, Germany|GSK Investigational Site, Leipzig, Sachsen, Germany|GSK Investigational Site, Berlin, Germany|GSK Investigational Site, Berlin, Germany|GSK Investigational Site, Berlin, Germany|GSK Investigational Site, Berlin, Germany|GSK Investigational Site, Berlin, Germany|GSK Investigational Site, Bekkestua, Norway|GSK Investigational Site, Bergen, Norway|GSK Investigational Site, Elverum, Norway|GSK Investigational Site, Fredrikstad, Norway|GSK Investigational Site, Hamar, Norway|GSK Investigational Site, Haugesund, Norway|GSK Investigational Site, Skien, Norway","https://ClinicalTrials.gov/show/NCT00529516"
57,"Study Comparing the Immune Response and Safety of Fluarix and Fluzone Influenza Vaccines in Children","Completed","Has Results","Influenza","Biological: Fluarix™|Biological: Fluzone","GSK Investigational Site, Antioch, California, United States|GSK Investigational Site, Fairfield, California, United States|GSK Investigational Site, Fresno, California, United States|GSK Investigational Site, Pleasanton, California, United States|GSK Investigational Site, Redwood City, California, United States|GSK Investigational Site, Richmond, California, United States|GSK Investigational Site, Rolling Hills Estates, California, United States|GSK Investigational Site, Sacramento, California, United States|GSK Investigational Site, San Francisco, California, United States|GSK Investigational Site, San Francisco, California, United States|GSK Investigational Site, Santa Clara, California, United States|GSK Investigational Site, Santa Rosa, California, United States|GSK Investigational Site, Vacaville, California, United States|GSK Investigational Site, Vallejo, California, United States|GSK Investigational Site, Walnut Creek, California, United States|GSK Investigational Site, Englewood, Colorado, United States|GSK Investigational Site, Lakewood, Colorado, United States|GSK Investigational Site, Tifton, Georgia, United States|GSK Investigational Site, Bardstown, Kentucky, United States|GSK Investigational Site, Lexington, Kentucky, United States|GSK Investigational Site, Metairie, Louisiana, United States|GSK Investigational Site, Omaha, Nebraska, United States|GSK Investigational Site, Whitehouse Station, New Jersey, United States|GSK Investigational Site, Fishkill, New York, United States|GSK Investigational Site, Hopewell Junction, New York, United States|GSK Investigational Site, Poughkeepsie, New York, United States|GSK Investigational Site, Rochester, New York, United States|GSK Investigational Site, Rochester, New York, United States|GSK Investigational Site, Cary, North Carolina, United States|GSK Investigational Site, Sylva, North Carolina, United States|GSK Investigational Site, Cleveland, Ohio, United States|GSK Investigational Site, Pittsburgh, Pennsylvania, United States|GSK Investigational Site, Uniontown, Pennsylvania, United States|GSK Investigational Site, Austin, Texas, United States|GSK Investigational Site, Fort Worth, Texas, United States|GSK Investigational Site, San Angelo, Texas, United States|GSK Investigational Site, Layton, Utah, United States|GSK Investigational Site, Salt Lake City, Utah, United States|GSK Investigational Site, South Jordan, Utah, United States|GSK Investigational Site, West Jordan, Utah, United States","https://ClinicalTrials.gov/show/NCT00383123"
58,"Study Comparing the Immune Response of Fluarix and Fluzone Influenza Vaccines","Completed","No Results Available","Influenza","Biological: Influenza","GSK Investigational Site, Clearwater, Florida, United States|GSK Investigational Site, Evansville, Indiana, United States|GSK Investigational Site, Baltimore, Maryland, United States|GSK Investigational Site, St. Louis, Missouri, United States|GSK Investigational Site, Buffalo, New York, United States|GSK Investigational Site, Poughkeepsie, New York, United States|GSK Investigational Site, Cincinnati, Ohio, United States|GSK Investigational Site, Carnegie, Pennsylvania, United States|GSK Investigational Site, Erie, Pennsylvania, United States|GSK Investigational Site, Philadelphia, Pennsylvania, United States|GSK Investigational Site, Pittsburgh, Pennsylvania, United States|GSK Investigational Site, Warwick, Rhode Island, United States|GSK Investigational Site, Houston, Texas, United States|GSK Investigational Site, Katy, Texas, United States|GSK Investigational Site, Marshfield, Wisconsin, United States","https://ClinicalTrials.gov/show/NCT00197288"
59,"Comparison of Delivery Routes of Flu Vaccine in Adults","Completed","No Results Available","Influenza","Biological: Trivalent inactivated influenza vaccine","Stanford University School of Medicine, Stanford, California, United States|UCLA Center For Vaccine Research, Torrance, California, United States|University of Iowa - Vaccine Research & Education Unit, Iowa City, Iowa, United States|University of Maryland Baltimore, Baltimore, Maryland, United States|Saint Louis University, St. Louis, Missouri, United States|University of Rochester Medical Center - Strong Memorial Hospital - Infectious Diseases, Rochester, New York, United States|Duke Health Center, Durham, North Carolina, United States|Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, United States|Vanderbilt University, Nashville, Tennessee, United States|Baylor College of Medicine, Houston, Texas, United States","https://ClinicalTrials.gov/show/NCT00170547"
60,"A Phase 2 Study to Evaluate Immune Responses of FluMist®","Completed","Has Results","Influenza Vaccine","Biological: TIV, Trivalent Inactivated Influenza Virus Vaccine|Biological: FluMist, Influenza Virus Vaccine Live","Harvey Pediatrics, Jonesboro, Arkansas, United States|Arkansas Pediatric Clinic, Little Rock, Arkansas, United States|NuLife Clinical Research, Anaheim, California, United States|Palm Beach Research Center, West Palm Beach, Florida, United States|Central Kentucky Research Associates, Lexington, Kentucky, United States|Peak Medical Research, LLC, Owensboro, Kentucky, United States|Benchmark Research, Metairie, Louisiana, United States|Meridian Clinical Research, LLC, Omaha, Nebraska, United States|Henderson Pediatrics, Henderson, Nevada, United States|Regional Clinical Research, Inc., Endwell, New York, United States|Dayton Clinical Research, Dayton, Ohio, United States|Northeast Cincinnati Pediatric Asso., Inc., Mason, Ohio, United States|Celia Reyes-Acuna, M.D., Corpus Christi, Texas, United States|Allergy Immunology Research Center of North Texas, Dallas, Texas, United States|Healthcare Discoveries, Inc., San Antonio, Texas, United States|Wee Care Pediatrics, Layton, Utah, United States|Bear Care Pediatrics, Ogden, Utah, United States|Advanced Pediatrics, Vienna, Virginia, United States|Pediatrics at the Beach, Virginia Beach, Virginia, United States","https://ClinicalTrials.gov/show/NCT00461981"
61,"Comparison of the Immunogenicity, Safety and Reactogenicity of FluBlok, To a Licensed Vaccine In Elderly Adults","Completed","No Results Available","Influenza","Biological: Influenza Vaccination","Center of Vaccine Development, Univ. of Maryland, Baltimore, Maryland, United States|Passport Health Maryland, Baltimore, Maryland, United States|Mayo Clinic College of Medicine, Rochester, Minnesota, United States|Passport Health New Jersey, Shrewsbury, New Jersey, United States|Rochester Medical Center, Rochester, New York, United States|Primary Physicians Research, Pittsburg, Pennsylvania, United States|Baylor College of Medicine, Houston, Texas, United States","https://ClinicalTrials.gov/show/NCT00395174"
62,"Study of Inactivated, Split-Virion Influenza Vaccine Compared With Standard Fluzone Vaccine in Elderly Subjects","Completed","Has Results","Orthomyxoviridae Infection|Influenza|Myxovirus Infection","Biological: Split, Inactivated, Trivalent Influenza Vaccine","Alabaster, Alabama, United States|Tucson, Arizona, United States|Fountain Valley, California, United States|Pinellas Park, Florida, United States|Chicago, Illinois, United States|Springfield, Missouri, United States|Brooklyn, New York, United States|New York, New York, United States|Bensalem, Pennsylvania, United States|Grove City, Pennsylvania, United States|Johnstown, Pennsylvania, United States|Pittsburgh, Pennsylvania, United States|Fort Worth, Texas, United States|Galveston, Texas, United States|Layton, Utah, United States|South Jordan, Utah, United States|Norfolk, Virginia, United States","https://ClinicalTrials.gov/show/NCT00388583"
63,"Trial to Assess the Shedding,Immunogenicity, and Safety of FluMist Administered to Healthy Individuals 5-49 Years of Age","Completed","No Results Available","Influenza","Biological: FluMist","SFBC International, Inc, Miami, Florida, United States|Children's Memorial Hospital, Chicago, Illinois, United States|Kentucky Pediatric / Adult Research, Inc, Bardstown, Kentucky, United States|University of Maryland, School of Medicine, Baltimore, Maryland, United States|Center for Vaccine Development, Saint Louis, Missouri, United States|Creighton University Medical Center, Omaha, Nebraska, United States|Pediatric Clinical Trials International, Columbus, Ohio, United States|Primary Physician's Research Inc., Pittsburgh, Pennsylvania, United States|Vanderbilt University Medical Center North, Nashville, Tennessee, United States|University of Virginia, Elson Student Health Center, Charlottesville, Virginia, United States|Marshall University Medical Center, Huntington, West Virginia, United States","https://ClinicalTrials.gov/show/NCT00192140"
64,"Study of Inactivated, Split-Virion Influenza Vaccine Compared With Standard Fluzone Vaccine in Infants and Children","Completed","Has Results","Orthomyxoviridae Infection|Influenza|Myxovirus Infection","Biological: Split, Inactivated, Trivalent Influenza Vaccine|Biological: Split, Inactivated, Trivalent Influenza Vaccine ( Fluzone® 2006/2007 Formulation)","Harrisburg, Arkansas, United States|Little Rock, Arkansas, United States|Trumann, Arkansas, United States|Bellflower, California, United States|Downey, California, United States|Fountain Valley, California, United States|Paramount, California, United States|Owensboro, Kentucky, United States|Bossier City, Louisiana, United States|Shreveport, Louisiana, United States|Brainerd, Minnesota, United States|Cleveland, Ohio, United States|Erie, Pennsylvania, United States|Pittsburgh, Pennsylvania, United States|Uniontown, Pennsylvania, United States|Wexford, Pennsylvania, United States|Fort Worth, Texas, United States|Salt Lake City, Utah, United States|Salt Lake City, Utah, United States","https://ClinicalTrials.gov/show/NCT00391391"
65,"Immunogenicity of High-dose Inactivated, Split-virion Influenza Vaccine Versus Standard Fluzone Vaccine in the Elderly","Completed","Has Results","Orthomyxoviridae Infection|Influenza|Myxovirus Infection","Biological: High-Dose Inactivated, Split-Virion Influenza Vaccine|Biological: Inactivated, Split-Virion Influenza Vaccine","Mesa, Arizona, United States|Phoenix, Arizona, United States|Tempe, Arizona, United States|Tucson, Arizona, United States|San Diego, California, United States|Stratford, Connecticut, United States|Clearwater, Florida, United States|Coral Gables, Florida, United States|Orlando, Florida, United States|Pembroke Pines, Florida, United States|Wichita, Kansas, United States|Rockville, Maryland, United States|Rochester, Minnesota, United States|Kansas City, Missouri, United States|St. Louis, Missouri, United States|Endwell, New York, United States|Rochester, New York, United States|Cary, North Carolina, United States|Raleigh, North Carolina, United States|Downington, Pennsylvania, United States|Erie, Pennsylvania, United States|Warwick, Rhode Island, United States|Dallas, Texas, United States|Plano, Texas, United States|West Jordan, Utah, United States|Norfolk, Virginia, United States|Richmond, Virginia, United States|Marshfield, Wisconsin, United States","https://ClinicalTrials.gov/show/NCT00391053"
66,"Safety of Hib-MenCY-TT Vaccine Versus Licensed Hib Conjugate Vaccine, Given at 2, 4, 6 and 12 to 15 Months of Age","Completed","Has Results","Haemophilus Influenzae Type b|Neisseria Meningitidis","Biological: GSK Biologicals' Haemophilus influenzae type b and Neisseria meningitidis serogroups C and Y-tetanus toxoid conjugate vaccine combined 792014|Biological: ActHIB|Biological: Pediarix/Infanrix Penta","GSK Investigational Site, Birmingham, Alabama, United States|GSK Investigational Site, Birmingham, Alabama, United States|GSK Investigational Site, Benton, Arkansas, United States|GSK Investigational Site, Fayetteville, Arkansas, United States|GSK Investigational Site, Hot Springs, Arkansas, United States|GSK Investigational Site, Jonesboro, Arkansas, United States|GSK Investigational Site, Little Rock, Arkansas, United States|GSK Investigational Site, Little Rock, Arkansas, United States|GSK Investigational Site, Fountain Valley, California, United States|GSK Investigational Site, Fresno, California, United States|GSK Investigational Site, Fresno, California, United States|GSK Investigational Site, Madera, California, United States|GSK Investigational Site, Slinas, California, United States|GSK Investigational Site, West Covina, California, United States|GSK Investigational Site, Boulder, Colorado, United States|GSK Investigational Site, Longmont, Colorado, United States|GSK Investigational Site, Plantation, Florida, United States|GSK Investigational Site, Nampa, Idaho, United States|GSK Investigational Site, Oaklawn, Illinois, United States|GSK Investigational Site, Waukee, Iowa, United States|GSK Investigational Site, West Desmoines, Iowa, United States|GSK Investigational Site, Bardstown, Kentucky, United States|GSK Investigational Site, Lexington, Kentucky, United States|GSK Investigational Site, Bossier City, Louisiana, United States|GSK Investigational Site, Boston, Massachusetts, United States|GSK Investigational Site, Jamaica Plain, Massachusetts, United States|GSK Investigational Site, Nies, Michigan, United States|GSK Investigational Site, Portage, Michigan, United States|GSK Investigational Site, Stevensville, Michigan, United States|GSK Investigational Site, St. Paul, Minnesota, United States|GSK Investigational Site, Las Vegas, Nevada, United States|GSK Investigational Site, New Hartford, New York, United States|GSK Investigational Site, Syracuse, New York, United States|GSK Investigational Site, Clyde, North Carolina, United States|GSK Investigational Site, Deerfield, North Carolina, United States|GSK Investigational Site, Raleigh, North Carolina, United States|GSK Investigational Site, Sylva, North Carolina, United States|GSK Investigational Site, Akron, Ohio, United States|GSK Investigational Site, Canton, Ohio, United States|GSK Investigational Site, Cleveland, Ohio, United States|GSK Investigational Site, North Canton, Ohio, United States|GSK Investigational Site, South Euclid, Ohio, United States|GSK Investigational Site, Pittsburgh, Pennsylvania, United States|GSK Investigational Site, Pittsburgh, Pennsylvania, United States|GSK Investigational Site, Pittsburgh, Pennsylvania, United States|GSK Investigational Site, Pittsburgh, Pennsylvania, United States|GSK Investigational Site, Wexford, Pennsylvania, United States|GSK Investigational Site, Charleston, South Carolina, United States|GSK Investigational Site, Kingsport, Tennessee, United States|GSK Investigational Site, Kingsport, Tennessee, United States|GSK Investigational Site, Houston, Texas, United States|GSK Investigational Site, Katy, Texas, United States|GSK Investigational Site, Layton, Utah, United States|GSK Investigational Site, Ogden, Utah, United States|GSK Investigational Site, Orem, Utah, United States|GSK Investigational Site, Pleasant Gorve, Utah, United States|GSK Investigational Site, Salt Lake City, Utah, United States|GSK Investigational Site, South Jordan, Utah, United States|GSK Investigational Site, West Jordan, Utah, United States|GSK Investigational Site, Madison, Wisconsin, United States|GSK Investigational Site, Marshfield, Wisconsin, United States|GSK Investigational Site, Mexico city, Mexico|GSK Investigational Site, Mexico, D.F., Mexico","https://ClinicalTrials.gov/show/NCT00345579"
67,"Safety and Immunogenicity Study of Hib-MenCY-TT Vaccine Compared to Licensed Hib Conjugate Vaccine","Completed","Has Results","Haemophilus Influenzae Type b|Neisseria Meningitidis","Biological: GSK Biologicals' Haemophilus influenzae type b and Neisseria meningitidis 792014 vaccine|Biological: ActHIB|Biological: PedvaxHIB|Biological: Pediarix|Biological: Prevnar|Biological: M-M-R II|Biological: Varivax","GSK Investigational Site, Birmingham, Alabama, United States|GSK Investigational Site, Birmingham, Alabama, United States|GSK Investigational Site, Phoenix, Arizona, United States|GSK Investigational Site, Bryant, Arkansas, United States|GSK Investigational Site, Fayetteville, Arkansas, United States|GSK Investigational Site, Little Rock, Arkansas, United States|GSK Investigational Site, Little Rock, Arkansas, United States|GSK Investigational Site, East Artesia, California, United States|GSK Investigational Site, Fountain Valley, California, United States|GSK Investigational Site, Fresno, California, United States|GSK Investigational Site, Fresno, California, United States|GSK Investigational Site, Fresno, California, United States|GSK Investigational Site, La Jolla, California, United States|GSK Investigational Site, Oakland, California, United States|GSK Investigational Site, Paramount, California, United States|GSK Investigational Site, Rolling Hills Estates, California, United States|GSK Investigational Site, Sacramento, California, United States|GSK Investigational Site, West Covina, California, United States|GSK Investigational Site, Longmont, Colorado, United States|GSK Investigational Site, Norwich, Connecticut, United States|GSK Investigational Site, Cocoa Beach, Florida, United States|GSK Investigational Site, Melbourne, Florida, United States|GSK Investigational Site, Pembroke Pines, Florida, United States|GSK Investigational Site, Rockledge, Florida, United States|GSK Investigational Site, Nampa, Idaho, United States|GSK Investigational Site, Des Moines, Iowa, United States|GSK Investigational Site, Des Moines, Iowa, United States|GSK Investigational Site, Arkansas City, Kansas, United States|GSK Investigational Site, Kansas City, Kansas, United States|GSK Investigational Site, Bardstown, Kentucky, United States|GSK Investigational Site, Lexington, Kentucky, United States|GSK Investigational Site, Louisville, Kentucky, United States|GSK Investigational Site, Bossier City, Louisiana, United States|GSK Investigational Site, Baltimore, Maryland, United States|GSK Investigational Site, Boston, Massachusetts, United States|GSK Investigational Site, Fall River, Massachusetts, United States|GSK Investigational Site, Jamaica Plain, Massachusetts, United States|GSK Investigational Site, Kalamazoo, Michigan, United States|GSK Investigational Site, Portage, Michigan, United States|GSK Investigational Site, Stevensville, Michigan, United States|GSK Investigational Site, Brainerd, Minnesota, United States|GSK Investigational Site, Saint Paul, Minnesota, United States|GSK Investigational Site, Omaha, Nebraska, United States|GSK Investigational Site, North Las Vegas, Nevada, United States|GSK Investigational Site, Bronx, New York, United States|GSK Investigational Site, Ithaca, New York, United States|GSK Investigational Site, New Hartford, New York, United States|GSK Investigational Site, Rochester, New York, United States|GSK Investigational Site, Stony Brook, New York, United States|GSK Investigational Site, Syracuse, New York, United States|GSK Investigational Site, Durham, North Carolina, United States|GSK Investigational Site, Durham, North Carolina, United States|GSK Investigational Site, Raleigh, North Carolina, United States|GSK Investigational Site, Sylva, North Carolina, United States|GSK Investigational Site, Boardman, Ohio, United States|GSK Investigational Site, Canton, Ohio, United States|GSK Investigational Site, Cleveland, Ohio, United States|GSK Investigational Site, Columbus, Ohio, United States|GSK Investigational Site, Huber Heights, Ohio, United States|GSK Investigational Site, South Euclid, Ohio, United States|GSK Investigational Site, Tulsa, Oklahoma, United States|GSK Investigational Site, Gresham, Oregon, United States|GSK Investigational Site, Beaver Falls, Pennsylvania, United States|GSK Investigational Site, Erie, Pennsylvania, United States|GSK Investigational Site, Greenville, Pennsylvania, United States|GSK Investigational Site, Hershey, Pennsylvania, United States|GSK Investigational Site, Philadelphia, Pennsylvania, United States|GSK Investigational Site, Pittsburgh, Pennsylvania, United States|GSK Investigational Site, Pittsburgh, Pennsylvania, United States|GSK Investigational Site, Pittsburgh, Pennsylvania, United States|GSK Investigational Site, Pittsburgh, Pennsylvania, United States|GSK Investigational Site, Sellersville, Pennsylvania, United States|GSK Investigational Site, Providence, Rhode Island, United States|GSK Investigational Site, Charleston, South Carolina, United States|GSK Investigational Site, Lexington, South Carolina, United States|GSK Investigational Site, Amarillo, Texas, United States|GSK Investigational Site, Fort Worth, Texas, United States|GSK Investigational Site, Galveston, Texas, United States|GSK Investigational Site, San Antonio, Texas, United States|GSK Investigational Site, Temple, Texas, United States|GSK Investigational Site, Layton, Utah, United States|GSK Investigational Site, Pleasant Grove, Utah, United States|GSK Investigational Site, Saint George, Utah, United States|GSK Investigational Site, South Jordan, Utah, United States|GSK Investigational Site, Mechanicsville, Virginia, United States|GSK Investigational Site, Norfolk, Virginia, United States|GSK Investigational Site, Vancouver, Washington, United States|GSK Investigational Site, La Crosse, Wisconsin, United States|GSK Investigational Site, Randwick, New South Wales, Australia|GSK Investigational Site, Herston, Queensland, Australia|GSK Investigational Site, South Brisbane, Queensland, Australia|GSK Investigational Site, Carlton, Victoria, Australia|GSK Investigational Site, Mexico, D.F., Mexico","https://ClinicalTrials.gov/show/NCT00289783"
68,"Immunogenicity, Safety of GSKs Tdap Vaccine Boostrix When Coadministered With GSKs Influenza Vaccine Fluarix in Adults","Completed","Has Results","Acellular Pertussis|Diphtheria|Tetanus","Biological: Fluarix®|Biological: Boostrix®","GSK Investigational Site, Huntsville, Alabama, United States|GSK Investigational Site, Chandler, Arizona, United States|GSK Investigational Site, Mesa, Arizona, United States|GSK Investigational Site, Phoenix, Arizona, United States|GSK Investigational Site, Inverness, Florida, United States|GSK Investigational Site, Melbourne, Florida, United States|GSK Investigational Site, Pembroke Pines, Florida, United States|GSK Investigational Site, Peoria, Illinois, United States|GSK Investigational Site, Pittsburgh, Pennsylvania, United States|GSK Investigational Site, Pittsburgh, Pennsylvania, United States|GSK Investigational Site, Bristol, Tennessee, United States|GSK Investigational Site, Houston, Texas, United States","https://ClinicalTrials.gov/show/NCT00385255"
69,"Long-Term Antibody Persistence at 1, 3 and 5 Years After a Fourth Dose of GSK Biologicals' Hib-MenCY-TT Vaccine Compared to ActHIB","Completed","Has Results","Neisseria Meningitidis|Haemophilus Influenzae Type b","Biological: MenHibrix (Hib-MenCY-TT)|Biological: Hib conjugate vaccine (ActHIB)","GSK Investigational Site, Little Rock, Arkansas, United States|GSK Investigational Site, Fountain Valley, California, United States|GSK Investigational Site, Norwich, Connecticut, United States|GSK Investigational Site, Marietta, Georgia, United States|GSK Investigational Site, Woodstock, Georgia, United States|GSK Investigational Site, Waukee, Iowa, United States|GSK Investigational Site, Bardstown, Kentucky, United States|GSK Investigational Site, Louisville, Kentucky, United States|GSK Investigational Site, Louisville, Kentucky, United States|GSK Investigational Site, Bossier City, Louisiana, United States|GSK Investigational Site, Boston, Massachusetts, United States|GSK Investigational Site, Fall River, Massachusetts, United States|GSK Investigational Site, Pittsford, New York, United States|GSK Investigational Site, Rochester, New York, United States|GSK Investigational Site, Boardman, Ohio, United States|GSK Investigational Site, Cleveland, Ohio, United States|GSK Investigational Site, Erie, Pennsylvania, United States|GSK Investigational Site, Greenville, Pennsylvania, United States|GSK Investigational Site, Pittsburgh, Pennsylvania, United States|GSK Investigational Site, Pittsburgh, Pennsylvania, United States|GSK Investigational Site, Pittsburgh, Pennsylvania, United States","https://ClinicalTrials.gov/show/NCT00359983"
70,"Comparison of GSKBiologicals' Hib-MenCY-TT Vaccine vs Licensed Hib Conjugate or Meningococcal Vaccine","Completed","Has Results","Haemophilus Influenzae Type b|Neisseria Meningitidis","Biological: GSK Biologicals' Haemophilus influenza type b and Neisseria meningitidis serogroups C and Y-tetanus toxoid conjugate vaccine 792014 vaccine|Biological: ActHIB|Biological: Pediarix|Biological: Prevnar|Biological: Menomune","GSK Investigational Site, Little Rock, Arkansas, United States|GSK Investigational Site, Fountain Valley, California, United States|GSK Investigational Site, Centennial, Colorado, United States|GSK Investigational Site, Norwich, Connecticut, United States|GSK Investigational Site, Marietta, Georgia, United States|GSK Investigational Site, Des Moines, Iowa, United States|GSK Investigational Site, Bardstown, Kentucky, United States|GSK Investigational Site, Louisville, Kentucky, United States|GSK Investigational Site, Louisville, Kentucky, United States|GSK Investigational Site, Bossier City, Louisiana, United States|GSK Investigational Site, Boston, Massachusetts, United States|GSK Investigational Site, Boston, Massachusetts, United States|GSK Investigational Site, New Bedford, Massachusetts, United States|GSK Investigational Site, Bronx, New York, United States|GSK Investigational Site, Rochester, New York, United States|GSK Investigational Site, Boardman, Ohio, United States|GSK Investigational Site, University Heights, Ohio, United States|GSK Investigational Site, Beaver Falls, Pennsylvania, United States|GSK Investigational Site, Erie, Pennsylvania, United States|GSK Investigational Site, Greenville, Pennsylvania, United States|GSK Investigational Site, Norristown, Pennsylvania, United States|GSK Investigational Site, Pittsburgh, Pennsylvania, United States|GSK Investigational Site, Pittsburgh, Pennsylvania, United States|GSK Investigational Site, Pittsburgh, Pennsylvania, United States|GSK Investigational Site, Pittsburgh, Pennsylvania, United States|GSK Investigational Site, Rydal, Pennsylvania, United States|GSK Investigational Site, Warwick, Rhode Island, United States","https://ClinicalTrials.gov/show/NCT00129129"
71,"A Study to Evaluate the Shedding and Safety of Trivalent Influenza Virus Vaccine Live, Intranasal in Infants and Young Children","Completed","Has Results","Healthy","Biological: Trivalent influenza virus vaccine live, intranasal","Little Rock Allergy & Asthma Clinic, PA, Little Rock, Arkansas, United States|Pediatric and Adolescent Medicine, PA (PAMPA), Marietta, Georgia, United States|Kentucky Pediatrics/Adult Research, Bardstown, Kentucky, United States|Benchmark Research, Metairie, Louisiana, United States|Health Sciences Research Center, Cortland, New York, United States|Health Sciences Research Center, Elmira, New York, United States|Regional Clinical Research Inc., Endwell, New York, United States|Grand Prairie Pediatrics & Allergy Clinic, Oklahoma City, Oklahoma, United States|Primary Physicians Research , Inc, Pittsburgh, Pennsylvania, United States|Med-Pro Research Inc., Houston, Texas, United States|Central Texas Health Research, New Braunfels, Texas, United States|Benchmark Research, San Angelo, Texas, United States|Wee Care Pediatrics, Layton, Utah, United States|Utah Valley Pediatrics, Provo, Utah, United States|PI-Coor Clinical Research, LLC, Burke, Virginia, United States|Advanced Pediatrics, Vienna, Virginia, United States","https://ClinicalTrials.gov/show/NCT00344305"
72,"Study of the Safety, Immunogenicity and Lot Comparability of DAPTACEL When Administered With Other Recommended Vaccine","Completed","No Results Available","Diphtheria|Tetanus|Whooping Cough|Polio|Haemophilus Influenzae Type b","Biological: DAPTACEL® (Diphtheria and Tetanus Toxoids and Acellular Pertussis vaccine)|Biological: Pentacel: DTaP-IPV/Hib","Fayetteville, AR 72703, Arkansas, United States|Jonesboro, AR 72401, Arkansas, United States|Little Rock, AR 72211, Arkansas, United States|Fountain Valley, CA 92708, California, United States|Englewood, CO 80112, Colorado, United States|Norwich, CT 06360, Connecticut, United States|Orlando, FL 32856, Florida, United States|Marietta, GA 30062, Georgia, United States|Chicago, IL 60614, Illinois, United States|Bardstown, KY 40004, Kentucky, United States|Bossier City, LA 71111, Louisiana, United States|Bridgeton, MO 63044, Missouri, United States|Rochester, NY 14620, New York, United States|Chapel Hill, NC 27514, North Carolina, United States|Portland, OR 97201, Oregon, United States|Norristown, PA 19401, Pennsylvania, United States|Pittsburgh, PA 15213, Pennsylvania, United States|Pittsburgh, PA 15241, Pennsylvania, United States|Kingsport, TN 37664, Tennessee, United States|Austin, TX 78758, Texas, United States|Fort Worth, TX 76107, Texas, United States|San Antonio, TX 78205, Texas, United States|Provo, UT 84604, Utah, United States|Spokane, WA 99220, Washington, United States|LaCrosse, WI 54601, Wisconsin, United States|Marshfield, WI 54449, Wisconsin, United States","https://ClinicalTrials.gov/show/NCT00662870"
73,"Study of the Effect of Pneumococcal Conjugate Vaccine (PCV) on Immunogenicity of Pentacel™","Completed","Has Results","Diphtheria|Tetanus|Haemophilus Infection|Pertussis|Polio","Biological: Pentacel™: HCPDT-IPV//PRP-T Vaccine and Prevnar®","Montgomery, Alabama, United States|Fayetteville, Arkansas, United States|Jonesboro, Arkansas, United States|Little Rock, Arkansas, United States|Fountain Valley, California, United States|Oakland, California, United States|Rolling Hills Estate, California, United States|Norwich, Connecticut, United States|Bardstown, Kentucky, United States|Louisville, Kentucky, United States|Boston, Massachusetts, United States|Kansas City, Missouri, United States|Brooklyn, New York, United States|Norristown, Pennsylvania, United States|Pittsburgh, Pennsylvania, United States|Austin, Texas, United States|Fort Worth, Texas, United States|San Antonio, Texas, United States|San Antonio, Texas, United States|Layton, Utah, United States|Spokane, Washington, United States|Vancouver, Washington, United States|Lacrosse, Wisconsin, United States","https://ClinicalTrials.gov/show/NCT00772928"
74,"Study of DAPTACEL® Administered as a 5th Dose in 4 to 6-Year-Old Children Previously Immunized With PENTACEL™","Completed","Has Results","Diphtheria|Tetanus|Pertussis|Polio|Haemophilus Infection","Biological: Diphtheria and Tetanus Toxoids and Acellular Pertussis (DAPTACEL®)","Jonesboro, Arkansas, United States|Little Rock, Arkansas, United States|Oakland, California, United States|Torrance, California, United States|Orlando, Florida, United States|Atlanta, Georgia, United States|Boston, Massachusetts, United States|Woburn, Massachusetts, United States|Omaha, Nebraska, United States|Albany, New York, United States|Rochester, New York, United States|Chapel Hill, North Carolina, United States|Sylva, North Carolina, United States|Pittsburgh, Pennsylvania, United States|Nashville, Tennessee, United States|San Antonio, Texas, United States|Layton, Utah, United States|Vancouver, Washington, United States|Marshfield, Wisconsin, United States","https://ClinicalTrials.gov/show/NCT00802867"
